COO buying at AREV Brands Intl (C:AREV)

Colin Job, a Senior Officer and Director, acquired 500,000 Common Shares on a direct ownership basis at a price of $0.300 through a prospectus or prospectus exempt offering on May 6th, 2019. The insider also acquired 500,000 Warrants with an exercise price of $0.500 for one year. This represents a $150,000 net investment into the company's shares and an account share holdings change of greater than 100%.

AREV Brands International Ltd. (“AREV”) produces and delivers functional compounds and ingredients from its extraction systems. AREV is focusing on revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.